Pharmaceutical Amid unprecedented demand, the supply of tocilizumab has dried up in India. As India's coronavirus cases surge past the five million mark on Wednesday after the Ministry of Health reported a single-day jump of 90,123 cases, the Central Drugs Standard Control Organization (CDSCO) has requested the Drug Controllers of all states to take immediate measures to prevent black marketing of remdesivir injections and has asked doctors not to prescribe tocilizumab randomly, reports The Pharma Letter’s India correspondent. 17 September 2020